Infotel SA (INF)
Euronext Paris · France · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 40.60 |
|---|---|
| 52-week range | 33.50 – 44.20 |
| Return, 1 month / 3 months | +1.2% / +4.2% |
| Return, 1 year / 3 years | +6.7% / +11.6% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 30.9% |
| Worst drawdown (1 year) | -21.3% |
| Average daily value traded | 0.17M EUR |
| Dividend yield | 4.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Infotel is a French information technology services company that helps large organisations design, build and run their computer systems. Its consultants work on database management, software engineering and application integration, often around enterprise and open-source platforms. The company serves corporate clients in sectors such as banking, insurance, industry and public services, and it is based in France, where much of its business is concentrated.
On this site Infotel SA appears as a stock on the Euronext Paris (France), code INF, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Infotel SA (INF) trades on the Euronext Paris in France. It last closed at EUR 40.60 on 27 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 40 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.7% and over the last three months it rose 4.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.4% | ||
| From 52-week high | -6.9% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 4.2% | ||
| 6-month return | 19.9% | ||
| 12-month return, skipping the last month | 5.4% | ||
| Stability (higher is calmer) | 74 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.3% | ||
| Liquidity | 67 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.17M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.2% |
|---|---|
| 1 month | +1.2% |
| 3 months | +4.2% |
| 6 months | +19.9% |
| 1 year | +6.7% |
| 3 years | +11.6% |
| 5 years | +0.4% |
Signals
| 50-day / 200-day average | 39.37 / 37.80 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.02 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Jun 2026 | EUR 2.0000 |
| 4 Jun 2025 | EUR 2.0000 |
| 29 May 2024 | EUR 2.0000 |
| 19 May 2023 | EUR 2.0000 |
| 27 May 2022 | EUR 1.6000 |
| 24 May 2021 | EUR 1.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.